» Articles » PMID: 10659702

11beta-hydroxysteroid Dehydrogenase Functions Reversibly As an Oxidoreductase in the Rat Hippocampus in Vivo

Overview
Date 2000 Feb 5
PMID 10659702
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The localization in the brain and metabolism of 3H-labeled corticosterone (B) and 11-dehydrocorticosterone (A) of high specific radioactivity was determined after stereotaxic injection into the hippocampus of anesthetized rats. [3H]B was cleared very rapidly with, on average, only about 7% being recovered after 5 min and 0.5% after 30 min. Most of this 3H-radioactivity was localized in the area surrounding the site of injection with little diffusion to adjacent areas. These findings make it possible to compare the short term metabolism of [3H]A and [3H]B in different lobes of the hippocampus in the same animal and establish their local equilibrium point in vivo. Under these conditions, about 5% conversion of each steroid to the other was observed in contrast to the situation in cultured hippocampal cells where 11beta-hydroxysteroid dehydrogenase (11-HSD) has been shown by others to act primarily as a reductase catalyzing the conversion of A to B. This method can also be used to study the effect of inhibitors such as 11alpha-hydroxyprogesterone, applied locally in the brain, on the metabolism of corticosteroids. The rate of conversion [3H]B or [3H]A to their dihydro- and tetrahydro-derivatives capable of modulating the GABAa receptor in the hippocampus was much lower than their interconversion. Thus, factors which influence the direction of the 11-HSD catalyzed reaction are important in regulating not only salt appetite and blood pressure but also the levels of neuroactive metabolites of corticosterone.

Citing Articles

11β-hydroxysteroid dehydrogenases: A growing multi-tasking family.

Gomez-Sanchez E, Gomez-Sanchez C Mol Cell Endocrinol. 2021; 526:111210.

PMID: 33607268 PMC: 8108011. DOI: 10.1016/j.mce.2021.111210.


The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy.

Morgen K, Frolich L J Neural Transm (Vienna). 2015; 122(4):499-504.

PMID: 25673434 DOI: 10.1007/s00702-015-1377-5.